Protective role of SIRT1 in diabetic vascular dysfunction

Area of Science:

• Cellular senescence
• Metabolic homeostasis
• Vascular biology

Background:

• Calorie restriction (CR) extends lifespan across species by modulating protein activity.
• Sirtuin 1 (SIRT1), a mammalian homolog of yeast Sir2, influences cellular aging and metabolic regulation.
• The precise role of SIRT1 in human disease, particularly in relation to metabolic dysfunction, requires further elucidation.

Purpose of the Study:

• To investigate the role of SIRT1 in high glucose-induced endothelial cell senescence.
• To explore the mechanism linking SIRT1, p53, and vascular dysfunction in hyperglycemia.
• To determine the therapeutic potential of SIRT1 activation in diabetic vasculopathy.

Main Methods:

• Treatment of human endothelial cells with high glucose.
• Assessment of SIRT1 expression, p53 acetylation, and senescence markers.
• Genetic manipulation of SIRT1 and p53 in cellular and mouse models.
• Evaluation of vascular function in diabetic mice with Sirt1 activation.

Main Results:

• High glucose conditions reduced SIRT1 expression in human endothelial cells, leading to p53 activation and accelerated senescence.
• Overexpression of SIRT1 or p53 inhibition mitigated high glucose-induced endothelial senescence and dysfunction.
• Sirt1 activation in diabetic mice prevented hyperglycemia-induced vascular cell senescence and protected against vascular dysfunction.

Conclusions:

• Hyperglycemia induces vascular cell senescence through a novel mechanism involving SIRT1 and p53.
• SIRT1 plays a protective role in the development of diabetic vasculopathy.
• Targeting SIRT1 may offer a therapeutic strategy for managing diabetic vascular complications.